The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.

The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine is sowing uncertainty about other ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...

The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat ...

Per the Post, which first reported the story, “‘All new vaccines will undergo safety testing in placebo-controlled trials ...

Additional data required by the FDA are the latest evidence of what one analyst described as a “higher bar” for vaccines.

Ionis Pharmaceuticals unveiled results from a survey conducted by The Harris Poll showing that 91% of surveyed adults living ...

A major change in the way HHS plans to evaluate vaccine safety is raising fears that approvals will become unnecessarily ...

WASHINGTON - The U.S. Department of Health and Human Services announced this week that it will add a step to the testing of ...